ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

RXRX Recursion Pharmaceuticals Inc

9,17
-0,27 (-2,86%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Recursion Pharmaceuticals Inc RXRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,27 -2,86% 9,17 01:57:34
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,24 9,165 9,41 9,26 9,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202423:12EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
14.6.202422:29EDGAR2Form 144 - Report of proposed sale of securities
13.6.202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.6.202422:10EDGAR2Form 144 - Report of proposed sale of securities
11.6.202422:13EDGAR2Form 144 - Report of proposed sale of securities
07.6.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202415:00EDGAR2Form 8-K - Current report
06.6.202416:36EDGAR2Form 144 - Report of proposed sale of securities
06.6.202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.6.202418:30EDGAR2Form 144 - Report of proposed sale of securities
04.6.202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.6.202415:00GLOBERecursion to Participate in Upcoming Investor Conferences
31.5.202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202422:03EDGAR2Form 144 - Report of proposed sale of securities
29.5.202421:27GLOBEPower of Recursion OS on Display at Genome Scale in Nature..
24.5.202422:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24.5.202422:31EDGAR2Form 8-K - Current report
24.5.202422:30GLOBERecursion Appoints Robert Hershberg M.D., Ph.D, as New Chair..
18.5.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.5.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.5.202422:25EDGAR2Form 144 - Report of proposed sale of securities
13.5.202411:00GLOBERecursion Announces Completion of NVIDIA-Powered BioHive-2,..
09.5.202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202422:01GLOBERecursion Provides Business Updates and Reports First..
02.5.202414:00GLOBERecursion to Report First Quarter 2024 Business Updates and..
01.5.202414:01GLOBERecursion to Participate in Upcoming Investor Conferences
30.4.202414:00GLOBEAltitude Lab Secures Small Business Administration Growth..
16.4.202414:00GLOBERecursion Appoints Najat Khan, PhD, as Chief R&D Officer and..
02.4.202414:00GLOBERecursion to Participate in Upcoming Investor Conference
26.3.202413:00GLOBERecursion Publishes Annual Environmental, Social and..
11.3.202409:00GLOBERecursion Announces Plans to Open New Office in London
09.3.202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:39EDGAR2Form 144 - Report of proposed sale of securities
06.3.202422:59EDGAR2Form 144 - Report of proposed sale of securities
05.3.202422:18EDGAR2Form 144 - Report of proposed sale of securities
01.3.202420:58GLOBERecursion Hosts Second Annual Rare Disease Day Events for..
01.3.202413:59GLOBERecursion to Participate in Upcoming Investor Conferences
29.2.202414:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202422:05GLOBERecursion Provides Business Updates and Reports Fourth..
24.2.202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:13EDGAR2Form 144 - Report of proposed sale of securities
21.2.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:29EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

Delayed Upgrade Clock